Genome-wide analysis identifies NR4A1 as a key mediator of T cell dysfunction
Xindong Liu,Yun Wang,Huiping Lu,Jing Li,Xiaowei Yan,Minglu Xiao,Jing Hao,Andrei Alekseev,Hiep Khong,Tenghui Chen,Rui Huang,Jin Wu,Qiwen Zhao,Qi Wu,Senlin Xu,Xiaohu Wang,Wei Jin,Shicang Yu,Yan Wang,Lai Wei,Aibo Wang,Bo Zhong,Ling Ni,Xiaolong Liu,Roza Nurieva,Lilin Ye,Qiang Tian,Xiu-Wu Bian,Chen Dong
DOI: https://doi.org/10.1038/s41586-019-0979-8
IF: 64.8
2019-02-27
Nature
Abstract:T cells become dysfunctional when they encounter self antigens or are exposed to chronic infection or to the tumour microenvironment1. The function of T cells is tightly regulated by a combinational co-stimulatory signal, and dominance of negative co-stimulation results in T cell dysfunction2. However, the molecular mechanisms that underlie this dysfunction remain unclear. Here, using an in vitro T cell tolerance induction system in mice, we characterize genome-wide epigenetic and gene expression features in tolerant T cells, and show that they are distinct from effector and regulatory T cells. Notably, the transcription factor NR4A1 is stably expressed at high levels in tolerant T cells. Overexpression of NR4A1 inhibits effector T cell differentiation, whereas deletion of NR4A1 overcomes T cell tolerance and exaggerates effector function, as well as enhancing immunity against tumour and chronic virus. Mechanistically, NR4A1 is preferentially recruited to binding sites of the transcription factor AP-1, where it represses effector-gene expression by inhibiting AP-1 function. NR4A1 binding also promotes acetylation of histone 3 at lysine 27 (H3K27ac), leading to activation of tolerance-related genes. This study thus identifies NR4A1 as a key general regulator in the induction of T cell dysfunction, and a potential target for tumour immunotherapy.
multidisciplinary sciences